Clinical Trial Update: Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial studying 99mTc-glucarate to detect acute coronary syndrome in chest pain patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• 99mTc-glucarate (technetium-99m glucarate)

Snippet

Sponsor: Molecular Targeting Technologies, Inc. | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED